lohud.com

Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Archive for the 'Research' Category

Library system plans business workshops

March
20

The Westchester Library System will launch a workshop series, “Your Business is Our Business,” at area libraries. The program will show businesspeople how to effectively search commercial databases, research trends that impact their industries, review magazines and trade journals, and use other library tools to grow business.
The first workshop is Thursday, March 26, at 11 a.m. at Stark Business Solutions, 100 S. Bedford Road, Mount Kisco. The event will be hosted by Mount Kisco Library, which is closed for construction.
For more information, or to schedule a workshop or tutorial at an area company, contact Kate Meyer at kmeyer@wlsmail.org or (914) 231.3226.

Posted by Jerry Gleeson on Friday, March 20th, 2009 at 4:35 pm |
| | Comments Off on Library system plans business workshops

IBM helps build world’s first memory chip using 22-nanometer technology

August
19

IBM Corp. and its development partners at a microchip research laboratory in Albany have built the world’s first memory chip using 22-nanometer technology.

A nanometer is one-billionth of a meter, or about 80,000 times thinner than a human hair.

T.C. Chen, vice president of science and technology at IBM Research in Yorktown Heights, said the breakthrough is a key achievement in the continued miniaturization of microelectronics. “We are working at the ultimate edge of what is possible,” Chen said.

The chip size of 22 nanometers is two generations away from today’s smallest scale for chip manufacturing, which is 45 nanometers. That’s the size IBM employs at its giant chip plant in East Fishkill.

IBM’s work in Albany is with AMD, Freescale, STMicroelectronics, Toshiba and the College of Nanoscale Science and Engineering at SUNY-Albany.

The Albany site is the most advanced university-based nanoelectronics research complex in the world, IBM said.

Last month, IBM said it would expand its operations at Albany NanoTech by investing about $375 million, which is expected to create 325 research and development jobs there. The state will provide $25 million in aid as well.

The deal was part of a larger $1.5 billion investment in New York facilities by IBM and a total state aid package of $140 million.

Posted by Julie Moran Alterio on Tuesday, August 19th, 2008 at 11:09 am |
| | Comments Off on IBM helps build world’s first memory chip using 22-nanometer technology

Progenics stock rises on drug trial news

May
22

Progenics Pharmaceuticals Inc. of Eastview and its research partner, Wyeth Pharmaceuticals, announced good and bad news concerning drug trials on its treatment for side effects of painkillers. Investors focused on the positive, and Progenics stock rose 9.79 percent today.
The companies said that a phase 2 study of an oral form of its Relistor drug for the treatment of constipation showed statistically significant improvements in patients. A phase 3 study of an intravenous form of Relistor on post-operative gastrointestinal function, however, fell short of research goals.
Progenics stock closed at $14.47, up $1.29.

Posted by Jerry Gleeson on Thursday, May 22nd, 2008 at 4:17 pm |
| | Comments Off on Progenics stock rises on drug trial news

Advertisement

Regeneron stock falls on test data

May
21

Disappointing data in a clinical trial of a treatment for ovarian cancer sent stock in Regeneron Pharmaceuticals Inc. of Eastview tumbling today.
The company and its research partner, Sanofti-aventis of Paris, said that a phase 2 study of 215 women with advanced ovarian cancer showed no significant response to a drug called aflibercept. The compound is a fused protein that aims to inhibit the growth of tumors by starving them of blood.
Regeneron stock was down as much as 16 percent. It closed yesterday at $18.58, down $2.89 or 13.5 percent. It was down 23.1 percent for the year.
In a statement, the company said there are few treatment options for advanced ovarian cancer.
“We and Sanofi-aventis are continuing to evaluate the data from this trial in order to determine the next steps for aflibercept in advanced ovarian cancer,” Dr. George Yancopoulos, Regeneron’s president, said in the statement.
Sanofi is Regeneron’s largest shareholder, with 19 percent of its stock.
Joseph Pantginis, an analyst who follows the company for Canaccord Adams, said part of the selloff in the stock may have been related to the larger drop in the markets yesterday. The announcement contained some good news about other drug trial results, he said, and Regeneron and Sanofi are testing aflibercept in four phase 3 trials that combine the drug with chemotherapy.
“Overall, the profile of the drug still looks very promising for other indications,” said Pantginis, a former scientist at Regeneron. He said he holds no shares of company stock.

Posted by Jerry Gleeson on Wednesday, May 21st, 2008 at 3:43 pm |
| | Comments Off on Regeneron stock falls on test data

IBM computers to tackle global rice shortage

May
14

When you think of IBM, you think of computers, not rice bowls. But for the billions of people around the world who rely on rice as a staple food, a new initiative by Big Blue could mean heartier meals.

A worldwide network of computers created by IBM will be tackling the looming rice shortage by helping researchers at the University of Washington research stronger, more nutritious and climate-tolerant rice strains.

IBM’s World Community Grid — a network of more than 1 million personal computers linked together to donate idle time to science — has accepted the Nutritious Rice for the World project as its latest effort.

Robin Wilner, vice president of Global Community Initiatives at IBM’s Armonk headquarters, said this is the ninth project for the grid, which was started in 2004.

“As a corporation, we’re a member of all of the communities where IBMers live and work and where our customers live and work. We need to be involved in solving problems that affect those communities, whether it’s looking for a cure for AIDS, creating diagnostic tools for cancer or finding more nutritious, disease-resistant rice,” she said.

IBM is not only providing technical assistance to the project, it’s donating computer time. Almost a third of IBM’s employees have signed up to allow their PCs to be used by the World Community Grid’s projects.

“More than 100,000 of us have World Community Grid on our laptops. Whenever we are on the phone, like we are now, my laptop is working to find out about the proteins in rice because I’m not typing,” she said.

The idea behind the grid is that unused computer power can add up to deliver the performance of a supercomputer to an organization that couldn’t afford to buy one for itself.

The University of Washington researchers will use the grid in a project that is expected to take 12 to 18 months. Without IBM’s help, it would 200 years to complete the rice study using just the computers the researchers have at hand.

The project involves mapping the structure of rice proteins using three-dimensional models on the computer to find ones that yield more rice, repel bugs, resist drought or contain more nutrients.

Anyone with a computer and Internet access can donate their time.

The project is supported by a $2 million grant from the National Science Foundation.

Posted by Julie Moran Alterio on Wednesday, May 14th, 2008 at 4:57 pm |
| | Comments Off on IBM computers to tackle global rice shortage

Acorda has deal with Danish drugmaker

April
9

Acorda Therapeutics Inc. of Hawthorne said a Danish drug company will manufacture a key molecule in a substance that Acorda is using in toxicology studies and early phase clinical trials.
Acorda said the company, CMC ICOS Biologics of Copenhagen, will produce the molecule, GGF2, for Acorda’s neuregulin program. Terms of the deal were not announced. Neuregulins have the potential to be helpful in treatments for multiple sclerosis and stroke, Acorda said.

Posted by Jerry Gleeson on Wednesday, April 9th, 2008 at 12:44 pm |
| | Comments Off on Acorda has deal with Danish drugmaker

Advertisement

IBM researchers build tiny switch to route data

March
17

Researchers at IBM Corp’s Yorktown Heights research center have developed technology that allows information within a computer chip using light pulses  instead of electrons, the company said today.

In building the world’s tiniest nanophotonic switch, researchers have added an important building block to control the flow of information inside future chips and can significanty speed up chip performance while using less energy, IBM said.

Posted by David Schepp on Monday, March 17th, 2008 at 4:30 pm |
| | Comments Off on IBM researchers build tiny switch to route data

Advertisement
About this blog
Business in the Burbs is our online news blog about businesses based or operating in the Lower Hudson Valley. Visitors here will also find items of interest to consumers in the region. Most contributions are from business reporters and editors covering Westchester, Rockland and Putnam counties.

Subscribe

Get blog updates via email:




About the Authors

Categories

Other recent entries




Links

Monthly Archives